Table of Contents

2018-2023 Global Eplerenone Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Eplerenone Consumption 2013-2023
  • 2.1.2 Eplerenone Consumption CAGR by Region
• 2.2 Eplerenone Segment by Type
  • 2.2.1 25 mg Tablets
  • 2.2.2 50 mg Tablets
• 2.3 Eplerenone Consumption by Type
  • 2.3.1 Global Eplerenone Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Eplerenone Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Eplerenone Sale Price by Type (2013-2018)
• 2.4 Eplerenone Segment by Application
  • 2.4.1 Heart failure
  • 2.4.2 Hypertension
  • 2.4.3 Others
• 2.5 Eplerenone Consumption by Application
  • 2.5.1 Global Eplerenone Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Eplerenone Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Eplerenone Sale Price by Application (2013-2018)

3 Global Eplerenone by Players

• 3.1 Global Eplerenone Sales Market Share by Players
  • 3.1.1 Global Eplerenone Sales by Players (2016-2018)
  • 3.1.2 Global Eplerenone Sales Market Share by Players (2016-2018)
• 3.2 Global Eplerenone Revenue Market Share by Players
  • 3.2.1 Global Eplerenone Revenue by Players (2016-2018)
  • 3.2.2 Global Eplerenone Revenue Market Share by Players (2016-2018)
• 3.3 Global Eplerenone Sale Price by Players
• 3.4 Global Eplerenone Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Eplerenone Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Eplerenone Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Eplerenone by Regions

• 4.1 Eplerenone by Regions
  • 4.1.1 Global Eplerenone Consumption by Regions
  • 4.1.2 Global Eplerenone Value by Regions
• 4.2 Americas Eplerenone Consumption Growth
• 4.3 APAC Eplerenone Consumption Growth
• 4.4 Europe Eplerenone Consumption Growth
• 4.5 Middle East & Africa Eplerenone Consumption Growth

5 Americas

• 5.1 Americas Eplerenone Consumption by Countries
  • 5.1.1 Americas Eplerenone Consumption by Countries (2013-2018)
  • 5.1.2 Americas Eplerenone Value by Countries (2013-2018)
• 5.2 Americas Eplerenone Consumption by Type
• 5.3 Americas Eplerenone Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Eplerenone Consumption by Countries
  • 6.1.1 APAC Eplerenone Consumption by Countries (2013-2018)
  • 6.1.2 APAC Eplerenone Value by Countries (2013-2018)
• 6.2 APAC Eplerenone Consumption by Type
• 6.3 APAC Eplerenone Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Eplerenone by Countries
  • 7.1.1 Europe Eplerenone Consumption by Countries (2013-2018)
  • 7.1.2 Europe Eplerenone Value by Countries (2013-2018)
• 7.2 Europe Eplerenone Consumption by Type
• 7.3 Europe Eplerenone Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Eplerenone by Countries
  • 8.1.1 Middle East & Africa Eplerenone Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Eplerenone Value by Countries (2013-2018)
• 8.2 Middle East & Africa Eplerenone Consumption by Type
• 8.3 Middle East & Africa Eplerenone Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Eplerenone Distributors
• 10.3 Eplerenone Customer

11 Global Eplerenone Market Forecast

• 11.1 Global Eplerenone Consumption Forecast (2018-2023)
• 11.2 Global Eplerenone Forecast by Regions
  • 11.2.1 Global Eplerenone Forecast by Regions (2018-2023)
  • 11.2.2 Global Eplerenone Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Eplerenone Forecast by Type
• 11.8 Global Eplerenone Forecast by Application

12 Key Players Analysis

• 12.1 Pfizer
  • 12.1.1 Company Details
  • 12.1.2 Eplerenone Product Offered
  • 12.1.3 Pfizer Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Pfizer News
• 12.2 Sandoz
  • 12.2.1 Company Details
  • 12.2.2 Eplerenone Product Offered
  • 12.2.3 Sandoz Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Sandoz News
• 12.3 Apotex
  • 12.3.1 Company Details
  • 12.3.2 Eplerenone Product Offered
  • 12.3.3 Apotex Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Apotex News
• 12.4 Mylan
  • 12.4.1 Company Details
  • 12.4.2 Eplerenone Product Offered
  • 12.4.3 Mylan Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Mylan News
• 12.5 Accord Healthcare
  • 12.5.1 Company Details
  • 12.5.2 Eplerenone Product Offered
  • 12.5.3 Accord Healthcare Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Accord Healthcare News
• 12.6 Teva
  • 12.6.1 Company Details
  • 12.6.2 Eplerenone Product Offered
  • 12.6.3 Teva Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Teva News
• 12.7 Breckenridge Pharmaceutical
  • 12.7.1 Company Details
  • 12.7.2 Eplerenone Product Offered
  • 12.7.3 Breckenridge Pharmaceutical Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 Breckenridge Pharmaceutical News
• 12.8 Cadila Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Eplerenone Product Offered
  • 12.8.3 Cadila Pharmaceuticals Eplerenone Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.8.4 Main Business Overview
  • 12.8.5 Cadila Pharmaceuticals News

13 Research Findings and Conclusion

Eplerenone is a steroidal antimineralocorticoid of the spirolactone group that is used as an adjunct in the management of chronic heart failure.

According to this study, over the next five years the Eplerenone market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Eplerenone business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Eplerenone market by product type, application, key manufacturers and key regions and countries.

This study considers the Eplerenone value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
25 mg Tablets
50 mg Tablets
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Heart failure
Hypertension
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Sandoz
Apotex
Mylan
Accord Healthcare
Teva
Breckenridge Pharmaceutical
Cadila Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Eplerenone consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Eplerenone market by identifying its various subsegments.
Focuses on the key global Eplerenone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Eplerenone with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Eplerenone submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.